Changying Shi
Overview
Explore the profile of Changying Shi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
45
Citations
525
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Guo D, Shi C, Suo L, Ji X, Yue H, Yuan D, et al.
J Control Release
. 2024 May;
370:626-642.
PMID: 38734314
Severe nephrotoxicity and infusion-related side effects pose significant obstacles to the clinical application of Amphotericin B (AmB) in life-threatening systemic fungal infections. In pursuit of a cost-effective and safe formulation,...
2.
Yang X, Guo D, Ji X, Shi C, Messina J, Suo L, et al.
Acta Biomater
. 2024 Mar;
178:147-159.
PMID: 38447811
Wound infection commonly causes delayed healing, especially in the setting of chronic wounds. Local release of antibiotics is considered a viable approach to treat chronic wounds. We have developed a...
3.
Yang X, Guo D, Ji X, Shi C, Luo J
Macromol Rapid Commun
. 2023 Aug;
44(23):e2300322.
PMID: 37533180
Imbalanced immune regulation leads to the abnormal wound healing process, e.g., chronic unhealing wound or hypertrophic scar formation. Thus, the attenuation of the overflowing inflammatory factors is a viable approach...
4.
Ma J, Wang X, Gu R, Guo D, Shi C, Kollisch-Singule M, et al.
Shock
. 2023 Mar;
59(6):922-929.
PMID: 36939682
Background: The kidney is the most common extrapulmonary organ injured in sepsis. The current study examines the ability of aerosolized nanochemically modified tetracycline 3 (nCMT-3), a pleiotropic anti-inflammatory agent, to...
5.
Ji X, Shi C, Guo D, Yang X, Suo L, Luo J
Mol Pharm
. 2023 Mar;
20(4):2138-2149.
PMID: 36877183
Systemic fungal infections are an increasingly prevalent health problem. Amphotericin B (AmB), a hydrophobic polyene antibiotic, remains the drug of choice for life-threatening invasive fungal infections. However, it has dose-limiting...
6.
Ji X, Yang X, Shi C, Guo D, Wang X, Messina J, et al.
Adv Ther (Weinh)
. 2023 Jan;
5(10).
PMID: 36590645
Sepsis is a complex, life-threatening hyperinflammatory syndrome associated with organ failure and high mortality due to lack of effective treatment options. Here we report a core-shell hydrogel nanoparticle with the...
7.
Shi C, Li Y, Yang C, Qiao L, Tang L, Zheng Y, et al.
Front Immunol
. 2022 Aug;
13:946861.
PMID: 35967452
Background: Currently, no second-line systemic treatment regimen has been recommended in advanced biliary tract cancer (BTC). Cumulative clinical evidence showed that systemic treatment with tyrosine kinase inhibitors (TKIs) in combination...
8.
Shi C, Li Y, Geng L, Shen W, Sui C, Dai B, et al.
Eur J Cancer
. 2022 Jul;
174:313-314.
PMID: 35863939
No abstract available.
9.
Wang X, Shi C, Zhang L, Lin M, Guo D, Wang L, et al.
ACS Macro Lett
. 2022 Jun;
6(3):267-271.
PMID: 35650900
Structure-based nanocarrier design for protein delivery remains challenging and has rarely been documented in the literature. We herein present a facile computer-aided approach for rational and customized design of a...
10.
Meng Q, Wang X, Guo D, Shi C, Gu R, Ma J, et al.
Shock
. 2022 May;
57(5):749-758.
PMID: 35583915
Background: Intratracheal (IT) lipopolysaccharide (LPS) causes severe acute lung injury (ALI) and systemic inflammation. CMT-3 has pleiotropic anti-inflammatory effects including matrix metalloproteinase (MMP) inhibition, attenuation of neutrophil (PMN) activation, and...